Tue, Apr 21, 2026

9:30 AM – 2 PM (GMT+2)

IE TOWER
24th Floor

IE Tower, Paseo de la Castellana 259E

39
Registered

Registration

Options Sales Start Sales End Availability Price
Option RSVP

Sales Start Mar 13, 2026 at 1 AM Sales End Apr 21, 2026 at 1 AM Availability Unlimited Price FREE
Note: There is a limit at 1 ticket per person for this event.

Details

Celebrate the first GSK Gate2Health community meeting in 2026, with the presence of the main partners in the community, especially focusing on strengthening relations with academia through IE School of Science and Technology as a strategic partner for training future professionals in the field of healthcare innovation.

The event will also showcase success cases resulting from the open innovation model proposed by GSK through Gate2Health, as well as from former IE students and entrepreneurs.

Agenda (subjected to minor modification)
09:30–10:00 | Coffee
10:00–10:10 | Welcome 
10:10–10:40 | Presentación GSK–IE Biopharma & AI Gateway Program 
10:40–11:10 | From IE to Driving Healthcare Transformation (IE success case stories) 
11:10–11:30 | Coffee Break
11:30–12:00 | Navigating the Innovation Maze: Lessons Learned in Healthcare Innovation Adoption 
12:00–12:30 | From Innovation to Impact: Success Stories Shaping Today’s Healthcare 
12:30–13:00 | Drug Development Applied Research 4.0: Science, Data and New Technological Paradigms 
13:00–13:10 | Closure 
13:10–14:00 | Cocktail & Networking
-------------------------------------------------------------------------------
Programme Details

Master of Ceremonies
Luis Quevedo, Speaker and Communications Consultant

Welcome Note by Ikhlaq Sidhu, Dean, School of Science & Technology, IE University and Florencia Davel, VP and General Manager Spain. 

GSK–IE Biopharma & AI Gateway Program 
Introduction to the GSK–IE Biopharma & AI Gateway Specialization, an academic and interdisciplinary initiative designed by IE to focus on the drug development and approval process, as well as on emerging technologies such as AI and data analytics applied to healthcare innovation.

Moderator:
Jorge Pou, Director of Innovation, GSK Spain

Speakers:
  • David Barros, VP Global Health, GSK 
  • David Moure, Academic Director, AI & Biopharma Gateway Specialization, IE School of Science and Technology
     
From IE to Driving Healthcare Transformation 
Inspiring talks by former IE students who have developed successful entrepreneurial projects based on new health technologies.

Moderator:
Isabel Sanchez-Emmerich, Executive Director, Impact Xcelerator

Speakers: 
  • Mar Pujadas, Founder & CEO, Omniloy and IE Alumna
  • Maria Hahn,Founder & CEO, Nutrix and IE Alumna
     
Navigating the Innovation Maze: Lessons Learned in Healthcare Innovation Adoption 
Discussion of real challenges in taking AI and innovative technologies from pilot to impact: data quality, technological integration, organizational resistance, compliance, and real-world sustainability and scalability.

Moderator:
Izabel Alfany, European Head of Ecosystem, EIT Health Spain

Speakers:
  • Marc Puigvert – Business Manager, AI-Enabled Reading Services, Siemens Healthineers
  • Marcos Rubio Tucuvi - Founder and CTO, Tucuvi
     
From Innovation to Impact: Success Stories Shaping Tomorrow Today’s Healthcare 
Some examples of GSK-promoted innovation projects, explaining how each initiative was shaped jointly by clinical insight and advanced technological capabilities.
This panel will be in Spanish.

Moderator:
Pablo Hervás, Healthcare Transformation Director, GSK

Speakers:
  • Dra. Leonor Arenillas - Head of the Hematopathology Section, Hospital del Mar
  • Dr. Alberto Fernández Villar - Head of the Pulmonology Department, Hospital Álvaro Cunqueiro.
  • Dra. Mariana Muñoz Hospital- Specialist in Pulmonology, Universitario de Bellvitge
  • Dra.Inmaculada Salcedo - Head of the Department of Preventive Medicine, Leal Hospital Reina Sofia de Cordoba

Drug Research 4.0 Science, Data and New Technological Paradigms 
A discussion on how AI-driven methodologies and emerging technologies are accelerating drug discovery and clinical trials, and transforming traditional R&D workflows, including a showcase of real examples of faster, more predictive, and technology-enabled research pipelines.
 

Moderator: 

  • Joel Lelievre - Head of Scientific Operations, Global Health R&D Medicines, GSK

Speakers:
  • Nacho Molina, CNRS Research Director, specializing in advanced AI-driven biological and computational modeling for drug discovery and development 
  • Rubén Sanchez Garcia, Assistant Professor at IE, focused on computational methods and AI applications accelerating drug discovery and therapeutic design.
Dress Business Formal
Food Provided

Speakers

Ikhlaq Sidhu's profile photo

Ikhlaq Sidhu

Dean, School of Science and Technology

IE University

https://www.linkedin.com/in/ikhlaq/

Ikhlaq Sidhu is Dean and Professor at the School of Science and Technology at IE University in Madrid, Spain, since 2022, and has been the founding faculty director of UC Berkeley’s Sutardja Center for Entrepreneurship & Technology since 2005. He is the author of the book "Innovation Engineering." He co-developed the Berkeley Method of Entrepreneurship and created the ground-breaking Data-X Course at UC Berkeley. He has been a prolific researcher with seminal work in Internet communications, data, AI, and networks, with many awards and advisory roles.

Florencia Davel's profile photo

Florencia Davel

VP and General Manager

GSK Spain

Florencia Davel is the President of GSK Spain, a role she assumed in March 2026 following a distinguished 25-year career at Bristol Myers Squibb, where she most recently served as Global Commercial VP for Onco-Hematology.

David Barros-Aguirre's profile photo

David Barros-Aguirre

VP and Head of Global Health Medicines R&D at GSK

GSK Spain

Dr. David Barros-Aguirre is the VP and Head of Global Health Medicines R&D at GSK, based in Tres Cantos, Spain. He leads research focused on Global Health, specifically in the discovery and development of novel treatments for tuberculosis (TB) and other infectious diseases.

 

Jorge Pou's profile photo

Jorge Pou

Innovation & Commercial Acceleration Director at GSK Spain.

GSK Spain

Jorge Pou currently serves as the Innovation & Commercial Acceleration Director at GSK Spain, where he leads the company's efforts in digital transformation and artificial intelligence.

 

Isabel Sanchez-Emmerich's profile photo

Isabel Sanchez-Emmerich

Executive Director, Impact Xcelerator

IE University

Executive Director, IE Impact Xcelerator at IE School of Science and Technology.

Mar Pujadas's profile photo

Mar Pujadas

CEO and Co-Founder

Omniloy

Mar Pujadas is the CEO and Co-Founder of Omniloy, an AI-driven healthtech startup focused on transforming the healthcare sector through generative artificial intelligence. As the CEO of Omniloy, she leads the development of hospital assistants that support clinicians by automating clinical reports, managing diagnostic test requests, and optimising patient triage.

Maria Hahn's profile photo

Maria Hahn

CEO and CoFounder

Nutrix

Maria Hahn is the visionary founder and CEO of Nutrix, a Swiss health-tech startup specializing in AI-driven preventive care. With an educational background from IE Business School and MIT, she leverages extensive experience in global solution management to disrupt the medtech industry. Recognized as a "Digital Shaper" and one of Forbes Poland’s "Women to Watch," she is a prominent voice for female entrepreneurship in tech. 

Izabel Alfany's profile photo

Izabel Alfany

European Head of Ecosystem

EIT Health

Izabel Alfany is the Managing Director of EIT Health Spain, bringing over 16 years of expertise in life sciences and international health innovation to the role. She holds a PhD in Physiology from the University of Barcelona and a Master’s in Business Innovation, having previously led the health division at the Leitat Technological Center.

In her current leadership, she focuses on digital transformation, advocating for the European Health Data Space to improve patient outcomes through AI and collaborative data use. 

Marcos Rubio's profile photo

Marcos Rubio

Founder and CTO

Tucuvi

Marcos Rubio Rubio is the Co-Founder and Chief Technology Officer (CTO) of Tucuvi, a Madrid-based health-tech startup founded in September 2019. He leads the technical development of a clinical voice AI platform that automates patient monitoring through conversational agents like "LOLA".

Marc Puigvert's profile photo

Marc Puigvert

Business Manager, AI-Enabled Reading Services

Siemens Healthineers

Marc Puigvert is the Business Manager for AI-Enabled Reading Services (AIERS) at Siemens Healthineers, a role he has held since September 2024. Based in Southern Europe, he leads a multimodal AI platform designed to integrate decision support into daily clinical workflows.

Pablo Hervás's profile photo

Pablo Hervás

Healthcare Transformation Director

GSK

Pablo Hervás Ballesteros is the Healthcare Transformation Director at GSK Spain. He is a prominent figure in healthcare innovation, focusing on digital transformation, technology transfer, and unified healthcare models.

Dra. Leonor Arenilas's profile photo

Dra. Leonor Arenilas

Head of the Hematopathology Section

Hospital Clinic, Barcelona

Dr. Leonor Arenillas is also a member of the Board of Directors SEHH and a member of the SEHH digital transformation commission. She is also the Head of the Hematopathology section, Pathological Anatomy Service at Hospital Clinic, Barcelona.



 

Dr. Alberto Fernández Villar's profile photo

Dr. Alberto Fernández Villar

Head of the Pulmonology Department

Hospital Álvaro Cunqueiro

Dr. Alberto Fernández Villar. Head of the Pulmonology Service at the Álvaro Cunqueiro Hospital. Vigo Health Area. 

Dra. Inmaculada Salcedo's profile photo

Dra. Inmaculada Salcedo

Head of the Department of Preventive Medicine

Hospital Universitario Reina Sofía de Córdoba

Inmaculada Salcedo Leal is the Head of the Preventive Medicine and Public Health Service at the Hospital Universitario Reina Sofía de Córdoba. She gained significant public prominence as the spokesperson for the Andalusian COVID-19 Expert Group during the pandemic.

Dra. Mariana Muñoz Esquerre's profile photo

Dra. Mariana Muñoz Esquerre

Specialist, Pulmonology

Hospital Universitario de Bellvitge

Mariana Muñoz Esquerre is a specialist in Pulmonology at the Hospital Universitari de Bellvitge and has collaborated with UpHill Health, specifically on the Route2Spain project.

Joel Lelievre's profile photo

Joel Lelievre

Head of Scientific Operations, Global Health R&D Medicines

GSK, Spain

Joël Lelièvre is the Head of Scientific Operations, Global Health Medicines R&D at GSK, based in Madrid, Spain. His work primarily focuses on addressing diseases of the developing world, particularly through his leadership within the Tuberculosis Discovery Performing Unit.

Nacho Molina's profile photo

Nacho Molina

Professor

IE University

Nacho Molina is a Professor of Machine Learning and Data Science in Biotechnology at IE School of Science & Technology. He is a leading expert in the intersection of biophysics and AI, serving as the Head of the Health & MedTech Lab within the IEX Research Xcelerator.

Ruben Sanchez Garcia's profile photo

Ruben Sanchez Garcia

Assistant Professor

IE Uniersity

Dr. Rubén Sánchez-García is an Assistant Professor at the IE School of Science and Technology at IE University. His work focuses on the intersection of machine learning and structural biology, particularly in the fields of drug discovery and cryogenic electron microscopy (cryo-EM).

Hosted By

Sci-Tech School | Website | View More Events